File Download

There are no files associated with this item.

Supplementary

Conference Paper: Efficacy and safety of ropeginterferon alfa-2b for pre-fibrotic primary myelofibrosis and dipss low/intermediate-1 risk myelofibrosis: updated results and genomic characteristics (oral presentation)

TitleEfficacy and safety of ropeginterferon alfa-2b for pre-fibrotic primary myelofibrosis and dipss low/intermediate-1 risk myelofibrosis: updated results and genomic characteristics (oral presentation)
Authors
Singh, Gill Harinder HarryAu, Lester Siu ShanTsai, Yan YuLeung, Man Kit GarretYim, Rita Lok HayChin, Zan LynnLi, Wing Kan VivianLee, PaulSin, Chun FungHou, Hsin AnChen, Chih Cheng
Issue Date10-Jun-2023
Persistent Identifierhttp://hdl.handle.net/10722/340420

 

DC FieldValueLanguage
dc.contributor.authorSingh, Gill Harinder Harry-
dc.contributor.authorAu, Lester Siu Shan-
dc.contributor.authorTsai, Yan Yu-
dc.contributor.authorLeung, Man Kit Garret-
dc.contributor.authorYim, Rita Lok Hay-
dc.contributor.authorChin, Zan Lynn-
dc.contributor.authorLi, Wing Kan Vivian-
dc.contributor.authorLee, Paul-
dc.contributor.authorSin, Chun Fung-
dc.contributor.authorHou, Hsin An-
dc.contributor.authorChen, Chih Cheng -
dc.date.accessioned2024-03-11T10:44:30Z-
dc.date.available2024-03-11T10:44:30Z-
dc.date.issued2023-06-10-
dc.identifier.urihttp://hdl.handle.net/10722/340420-
dc.languageeng-
dc.relation.ispartofEuropean Hematology Association Annual Congress 2023 (08/06/2023-15/06/2023, Frankfurt)-
dc.titleEfficacy and safety of ropeginterferon alfa-2b for pre-fibrotic primary myelofibrosis and dipss low/intermediate-1 risk myelofibrosis: updated results and genomic characteristics (oral presentation)-
dc.typeConference_Paper-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats